REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 195,300 | $2,240,091 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 136,667 | $1,567,570 | 0.00% |
GTS SECURITIES LLC | 14,000 | $160,580 | 0.00% |
SIGNATUREFD, LLC | 838 | $9,612 | 0.00% |
Elequin Capital, LP | 16 | $184 | 0.00% |
HighTower Advisors, LLC | 300 | $1,042 | 0.00% |
BALDWIN BROTHERS LLC/MA | 500 | $5,735 | 0.00% |
Tower Research Capital LLC (TRC) | 939 | $10,770 | 0.00% |
Daiwa Securities Group Inc. | 331 | $4 | 0.00% |
Allworth Financial LP | 132 | $1,515 | 0.00% |
D. E. Shaw & Co., Inc. | 30,000 | $344,100 | 0.00% |
SIMPLEX TRADING, LLC | 18,980 | $217 | 0.00% |
ROYAL BANK OF CANADA | 72,263 | $830,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 308 | $3,533 | 0.00% |
BANK OF AMERICA CORP /DE/ | 120,909 | $1,386,827 | 0.00% |
STIFEL FINANCIAL CORP | 14,956 | $171,545 | 0.00% |
FIRST MANHATTAN CO. LLC. | 7 | $80 | 0.00% |
CENTRAL TRUST Co | 50 | $574 | 0.00% |
Russell Investments Group, Ltd. | 182 | $2,088 | 0.00% |
US BANCORP \DE\ | 3,275 | $37,564 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.